Clinical Trials Directory

Trials / Completed

CompletedNCT03161392

Correlation of Solitary Dilated Duct at Mammography With Ultrasonography and Anatomopathological Findings

Evaluation of Solitary Dilated Duct Visualized by Mammography in Correlation With Ultrasonography and Anatomopathological Findings.

Status
Completed
Phase
Study type
Observational
Enrollment
135 (actual)
Sponsor
Faculdade de Medicina do ABC · Academic / Other
Sex
Female
Age
30 Years – 90 Years
Healthy volunteers
Accepted

Summary

Mammograms performed at the Diagnostic Imaging Department of the "Instituto Brasileiro de Controle do Câncer" (IBCC - Brazilian Cancer Control Institute) will be prospectively evaluated. Patients who present a solitary dilated duct visualized by mammography will be submitted to breast ultrasonography. In case of detection of lesion, a percutaneous biopsy will be performed.

Detailed description

Purpose: To determinate the incidence, pathological significance and risk factors associated with the presence of solitary dilated duct visualized at mammography exam. Methods: Mammograms performed at the Diagnostic Imaging Department of the "Instituto Brasileiro de Controle do Câncer" (IBCC - Brazilian Cancer Control Institute) will be prospectively evaluated. Patients who present a solitary dilated duct visualized by mammography will be included in the study. These patients will be recalled in order to be submitted to an ultrasonography directed to the mammographic finding. Patients who present lesions on ultrasonography will undergo method-guided percutaneous biopsy. Patients with ductal ectasia, without evident lesions, will be followed for 2 years to evaluate stability by means of mammography or ultrasonography every 6-month intervals.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTFollow-upGroup "No ductal lesion" will be submitted to follow-up with periodic breast ultrasonography/mammography every 6 months for 2 years.
DIAGNOSTIC_TESTUltrasound-guided percutaneous biopsyGroup "Ductal lesion" will be submitted to ultrasound-guided percutaneous biopsy and the specimen will be histologically analysed.

Timeline

Start date
2016-03-16
Primary completion
2017-03-13
Completion
2019-07-29
First posted
2017-05-19
Last updated
2019-07-30

Source: ClinicalTrials.gov record NCT03161392. Inclusion in this directory is not an endorsement.